Increasing severity of atopic dermatitis is associated with a negative impact on work productivity among adults with atopic dermatitis in France, Germany, the U.K. and the U.S.A.-Reference-Cited by-同舟云学术

Increasing severity of atopic dermatitis is associated with a negative impact on work productivity among adults with atopic dermatitis in France, Germany, the U.K. and the U.S.A.

Published:2019-09-08 Issue:4 Volume:182 Page:1007-1016
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Andersen L.¹,Nyeland M.E.¹,Nyberg F.²

Affiliation:

1. LEO Pharma A/S Industriparken 55 DK‐2750 Ballerup Denmark

2. Medical Evidence and Observational Research Global Medical Affairs AstraZeneca SE‐431 83 Mölndal Sweden

Funder

AstraZeneca

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjd.18296

Reference18 articles.

1. Epidemiology of atopic dermatitis in adults: Results from an international survey

2. A Population-Based Survey of Eczema Prevalence in the United States

3. Adult eczema prevalence and associations with asthma and other health and demographic factors: A US population–based study

4. Sleep Disturbances in Adults with Eczema Are Associated with Impaired Overall Health: A US Population-Based Study

5. Eczema, atopy and allergen exposure in adults: a population-based study

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Term Impact of Atopic Dermatitis on Quality of Life;Dermatologic Clinics;2024-10

2. Healthcare of patients with atopic dermatitis by general practitioners – a nationwide survey in Germany;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2024-09-03

3. Prevalence of Atopic Dermatitis: A Systematic Review and Meta-Analysis;Dermatitis®;2024-08-12

4. Nemolizumab with concomitant topical therapy in adolescents and adults with moderate-to-severe atopic dermatitis (ARCADIA 1 and ARCADIA 2): results from two replicate, double-blind, randomised controlled phase 3 trials;The Lancet;2024-08

5. Strategic Approaches to Reducing the Burden of Atopic Dermatitis in the Middle East and Africa Region;Value in Health Regional Issues;2024-07